Tag: Coughs
Microbial Contamination Prompts Recall of Robitussin Honey Cough Syrup
Manufacturer says that no illnesses in customers using the product have yet been reported
Gefapixant Leads to Modest Improvements in Cough
Modest improvement seen in cough frequency, severity, and specific quality of life, but increase seen in treatment-, taste-related adverse events
Recent Increase Seen in Pediatric Benzonatate Exposure
77 percent of the cases of pediatric exposure reported to U.S. poison control centers were for unintentional exposure
Symptom Presentation Varies by SARS-CoV-2 Variant
During first wave of COVID-19, cough occurred first in the United States, while fever occurred first in China
CPAP, HFNO Not Tied to Greater SARS-CoV-2 Air, Surface Contamination
Another small study suggests cough poses higher risk for aerosol emission from the respiratory tract than CPAP, HFNO
COVID-19 Suspected for Surge in Medical Visits at End of 2019
Excess seen for visits with cough in outpatient clinics, ED; hospitalizations with acute respiratory failure
More Nighttime Coughing May Indicate Worse Asthma Control
Increase in coughing measured via smartphone app tied to worse control for same, subsequent week
Children’s Robitussin Honey Cough and Chest Congestion DM Recalled
Dosing cups missing some graduation markings
GI Manifestations Seen for Nearly One in Three With SARS-CoV-2
Significant portion have diarrhea, nausea, vomiting, and/or abdominal discomfort before respiratory symptoms
Gefapixant Promising for Relief of Unexplained Chronic Cough
Cough frequency significantly reduced after 12 weeks of gefapixant 50 mg versus placebo in phase 2b study
